benextramine and caproctamine

benextramine has been researched along with caproctamine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrisano, V; Bolognesi, ML; Budriesi, R; Cavalli, A; Cavrini, V; Melchiorre, C; Recanatini, M; Rosini, M; Tumiatti, V	1
Andrisano, V; Angeli, P; Banzi, R; Bartolini, M; Cavalli, A; Marucci, G; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V	1
Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V	1

Reviews

1 review(s) available for benextramine and caproctamine

Article	Year
Multi-target-directed ligands to combat neurodegenerative diseases. Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid	2008

Article

Year

Multi-target-directed ligands to combat neurodegenerative diseases.

Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3

Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid

2008

Other Studies

2 other study(ies) available for benextramine and caproctamine

Article	Year
Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease. Journal of medicinal chemistry, 1998, Oct-22, Volume: 41, Issue:22 Topics: Acetylcholinesterase; Alzheimer Disease; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Erythrocytes; Humans; Kinetics; Ligands; Models, Molecular; Polyamines; Receptor, Muscarinic M2; Receptors, Muscarinic; Structure-Activity Relationship	1998
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine. Journal of medicinal chemistry, 2003, Mar-13, Volume: 46, Issue:6 Topics: Acetylcholinesterase; Amides; Animals; Anisoles; Atrial Function; Butyrylcholinesterase; Cholinesterase Inhibitors; Diaphragm; Guinea Pigs; Heart Atria; Humans; In Vitro Techniques; Models, Molecular; Muscarinic Antagonists; Myocardial Contraction; Neuromuscular Blockade; Neuromuscular Junction; Polyamines; Rats; Receptor, Muscarinic M2; Receptors, Muscarinic; Stereoisomerism; Structure-Activity Relationship	2003

Article

Year

Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.

Journal of medicinal chemistry, 1998, Oct-22, Volume: 41, Issue:22

Topics: Acetylcholinesterase; Alzheimer Disease; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Erythrocytes; Humans; Kinetics; Ligands; Models, Molecular; Polyamines; Receptor, Muscarinic M2; Receptors, Muscarinic; Structure-Activity Relationship

1998

Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.

Journal of medicinal chemistry, 2003, Mar-13, Volume: 46, Issue:6

Topics: Acetylcholinesterase; Amides; Animals; Anisoles; Atrial Function; Butyrylcholinesterase; Cholinesterase Inhibitors; Diaphragm; Guinea Pigs; Heart Atria; Humans; In Vitro Techniques; Models, Molecular; Muscarinic Antagonists; Myocardial Contraction; Neuromuscular Blockade; Neuromuscular Junction; Polyamines; Rats; Receptor, Muscarinic M2; Receptors, Muscarinic; Stereoisomerism; Structure-Activity Relationship

2003